Skip to main content
Intended for UK Healthcare Professionals. This website contains promotional content.
Intended for IE Healthcare Professionals. This website contains promotional content.
Report adverse events

Prescribing information, details of adverse event reporting and indications can be found at the bottom of this page. HEPCLUDEX® (bulevirtide)▼ is subject to additional monitoring

HCV test and trace

Recorded: March 2nd 2023

Duration: 31:13

Dr Stuart McPherson, Consultant Hepatologist, Freeman Hospital, Newcastle presented the rationale, process and results from the first nine months of a test & trace pilot in HCV. Test & trace had been used successfully in the context of human immunodeficiency virus (HIV), but this was new territory for HCV. The North East and Cumbria region has the highest rates of HCV reinfection in the country, so a key objective of the scheme was to reach individuals who were potentially involved in clusters of HCV reinfection. With careful consenting and incentives, individuals with diagnosed HCV were asked to ‘bring a friend’ for testing. While the number of individuals actually bringing others to be tested was lower than hoped, those who did brought just over three people each and the pilot identified a significant number of people living with HCV. However, challenges remain in converting those with diagnosed HCV into those effectively treated for HCV.

Speaker biographies

Dr Stuart McPherson

Dr Stuart McPherson

Dr Stuart McPherson

Dr Stuart McPherson is a Consultant Liver Specialist who joined the Newcastle Hospitals in 2010.  He is currently Head of Department for Liver Medicine.

 

Stuart completed undergraduate medical training at St Andrews and Manchester Universities and subsequently undertook specialist training in Glasgow and Newcastle. In addition, he spent two years in Brisbane, Australia researching hepatitis C and fatty liver disease. 

 

Stuart manages patients with liver disease and runs specialist clinics for viral hepatitis, fatty liver disease and cirrhosis. In 2017 he led the team to win the prestigious Royal College of Physicians Quality Improvement Award for developing a decompensated cirrhosis care bundle that was shown to improve care of patients with cirrhosis and is now used in most centres in the UK.

You might also like

NHS Tayside's Cocoon project

Brian Stephens, Outreach Nurse Specialist, NHS Tayside, demonstrated how strong relationships and a holistic approach led to significant health improvements

Self-testing for blood borne viruses in NHS Grampian

Pauline Dundas, Lead Hepatology and Viral Hepatitis Nurse Specialist, Aberdeen Royal Infirmary demonstrated how DBST can effectively streamline the pathway to hepatitis C treatment

Increasing clinic attendance

Lisa Ellis, Clinical Nurse Specialist in Hepatology, Queen Elizabeth Hospital, Birmingham, shared innovative approaches to ensure hepatitis C treatment reaches those who need it

Liver Connect Meetings

LIVER Connect Meetings

As requested by attendees, a selection of webinars from 2022 onwards are now available to watch on demand

 

You can also register here to attend the live webinars

Sign up now

UK-UNB-0252

Date of preparation February 2025